Sign In
Buy AQSZF
$0.0026
+0 (+0%)
At Close: Jul 31, 2026
Aequus Pharmaceuticals says entrepreneur Marc Lustig will join board of directors
09:08am, Friday, 12'th Feb 2021
Aequus Pharmaceuticals Inc (CVE:AQS) (OTCMKTS:AQSZF) (FRA:AEQ) said that it intends to complete a non-brokered private placement of around 6.67 million units at a price of $0.15 each to raise $1 mill
Aequus Announces Marc Lustig Joining Board of Directors and Making Direct Equity Investment into the Company
08:00am, Friday, 12'th Feb 2021
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES
Aequus Pharma 2021 Outlook and Holiday Wishes
04:32pm, Wednesday, 23'rd Dec 2020
VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and prom
Aequus Announces Issuance of Stock Options
09:13pm, Tuesday, 08'th Dec 2020
VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a foc
Aequus Provides Third Quarter 2020 Financial Highlights
09:00am, Monday, 30'th Nov 2020
Record Third Quarter Revenues – 67% Increase Over Same Period Last Year Record Third Quarter Revenues – 67% Increase Over Same Period Last Year
Aequus Announces Anne Stevens' Leadership Change
08:30pm, Thursday, 12'th Nov 2020
VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and prom
